Last Nam

eFirst

MI

Highest Degree

Department (include unit no.)

Specialty

Institution

MD Anderson Em

ployee ID No. (required for all M

DACC employees):

Physician Yes

No

Street

CityState/Foreign Country/Zip or M

ail Code

Daytime Phone (w

ith area code) Cell Phone (w

ith area code)Fax (w

ith area code)

E-mail Address (please print)

Emergency Contact

Phone (with area code)

Credit Card Holder Nam

e (First/Last) Charge the follow

ing: VISA

MC

AMEX

Credit Card Num

berExpiration Date

Security Code/CVV/CSVCredit Card Holder Billing Address &

ZIP Code

MD

Anderson Interdepartm

ental Transfer (IDT) N

o.: *Fund Group 90 will not be accepted

Business U

nit D

epartment

Fund Group*

FundFund Type

Authorized Signature REQ

UIRED

for CREDIT CA

RD or ID

TIDT Approver N

ame (First/Last) please print

Lymphoma/Myeloma Update: Whats New for 2017? Patient Care Conference-Houston– April 1, 2017 176700/30/116769/41 – PS106691

THIS IS NOT A SELF-M

AILER - Address to:

Lymphom

a/Myelom

a Patient Care Conference Houston

Department of CM

E/Conference Managem

ent-Unit 1781The University of Texas M

D Anderson Cancer Center

PO Box 301407, Houston, TX 77230-1407or fax to 713-794-1724

Make check or m

oney order payable to: The University of Texas M

D Anderson Cancer Center

Registration Fee: $20

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t- Un

it 17

81Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r17

6700

/30/

1167

69/4

1 –

PS10

6691

PO B

ox 3

0140

7Ho

usto

n, Te

xas

7723

0-14

07

Non

-Pro

fit O

rg.

U.S

. Pos

tage

P A

I D

Hou

ston

, TX

Per

mit

No.

705

2

The University of TexasMD Anderson Cancer Centerpresents

Lymphoma/MyelomaUpdate for Patients:What’s New for 2017?In HoustonApril 1, 2017Omni Houston Westside13210 Katy FreewayHouston, Texas

Target AudienceThis conference will be of interest to patients with myeloma and lymphoma, their caregivers, and family.

Learning Objectives• Increase awareness of myeloma/lymphoma• Provide better understanding of transplant therapy• Provide information on new treatment options for newly diagnosed myeloma/lymphoma• Provide information on new treatment options for relapsed myeloma and lymphoma and

on clinical trial opportunities for patients• Build a bridge of knowledge, communication, and collaboration among cancer

constituencies, including researchers, healthcare professionals, patients and caregivers• Provide patients access to the experts with time to ask questions

Saturday, April 1, 20177:00 am Registration/Continental Breakfast/View Exhibits

Lymphoma Session8:00 Welcome

Fredrick B. Hagemeister, MD

8:15 Classifying the Lymphomas: Similarities or Differences? Jason R. Westin, MD

8:45 Drug Interactions and Costs: What and Why? Brandon Shank, Pharm D

9:00 CLL: Are We Ready for a Cure? William G. Wierda, MD, PhD

9:30 American Society of Hematology Meeting Updates in Lymphomas: What is New? Fredrick B. Hagemeister, MD

10:15 Break/Visit Exhibits

10:30 Current Clinical Trials in Lymphoma: How Do They Help? Michelle A. Fanale, MD

11:00 CAR-T Cell Therapy in Treatment of Lymphoma: A New Hope? Hun Ju Lee, MD

11:30 How Can We Minimize Toxicity in Cancer Management? David Hui, MD

Noon Long-term Care of the Survivor: Are We Ready for This? TBD

12:15 pm Lymphoma Session Wrap-up Fredrick B. Hagemeister, MD

12:40 Pick up Box Lunch

Myeloma Session1:00 Welcome

Robert Orlowski, MD, PhD

1:15 Myeloma 101/Overview/Prognosis and Risk Swaminathan P. Iyer, MD

1:45 Smoldering Myeloma Update Elisabet E. Manasanch, MD

2:15 Treatment Options for Newly Diagnosed Patients Krina Patel, MD

2:45 Break/Visit Exhibits

3:00 Stem Cell Transplantation 101: Latest Updates Understanding Maintenance Therapy Muzaffar H. Qazilbash, MD

3:30 Treatment Options for Relapsed Myeloma Sheeba K. Thomas, MD

4:00 Pipeline: New, Emerging, and Clinical Trials for Multiple Myeloma Robert Orlowski, MD, PhD

4:30 Survivorship: How to Cope With a Chronic Disease Rebecca Lu, MSN, FNP-C

5:00 Myeloma Session Wrap-Up and Closing Remarks Robert Orlowski, MD, PhD

5:15 Adjourn

The goal of this event is to answer patients’ questions about the newest research in myeloma and lymphoma. It offers strategies for dealing with issues faced by myeloma & lymphoma patients and caregivers. This event will increase awareness of myeloma and lymphoma and clinical trial opportunities available. By providing information about transplant therapy and treatment options for newly diagnosed or relapsed myeloma and lymphoma, we will build a bridge of knowledge, communication, and collaboration among researchers, healthcare professionals, patients, and caregivers.

MD Anderson FacultyFredrick B. Hagemeister, MDProfessorLymphoma/Myeloma

Michelle A. Fanale, MDAssociate ProfessorLymphoma/Myeloma

David Hui, MDAssociate ProfessorPalliative Care Medicine

Hun Ju Lee, MDAssistant ProfessorLymphoma/Myeloma

Rebecca Lu, MSN, FNP-CAdvanced Practice Registered NurseLymphoma/Myeloma

Elisabet E. Manasanch, MDAssistant ProfessorLymphoma/Myeloma

Robert Orlowski, MD, PhDChair Ad Interim & ProfessorLymphoma/Myeloma

Krina Patel, MDAssistant ProfessorStem Cell Transplantation

Muzaffar H. Qazilbash, MDProfessorStem Cell Transplantation

Brandon Shank, PharmDClinical Pharmacy SpecialistPharmacy Clinical Programs

Sheeba K. Thomas, MDAssociate ProfessorLymphoma/Myeloma

Jason R. Westin, MDAssistant ProfessorLymphoma/Myeloma

William G. Wierda, MD, PhDProfessorLeukemia

Guest FacultySwaminathan P. Iyer, MDProfessor Hematology/Medical OncologyThe Methodist Cancer CenterHouston, Texas

Conference ChairsRobert Orlowski, MD, PhDChair Ad Interim & ProfessorLymphoma/MyelomaMD Anderson

Frederick B. Hagemeister, MDProfessorLymphoma/MyelomaMD Anderson

Registration InformationOn-site registration opens at 7:00 am on Saturday, April 1, 2017 at the Omni Houston Westside Hotel. The opening session of the conference will begin at 8:00 am, and the conference will adjourn at 5:15 pm. Advanced registration is encouraged as space and materials are limited. See registration form for fee.

There are three ways to register:1. Register on-line at www.mdanderson.org/conferences2. Mail to Department of CME/Conference Services – Unit 1781

The University of Texas M. D. Anderson Cancer Center P.O. Box 301407, Houston, TX 77230-1407

3. Fax to 713-794-1724

We accept the following forms of payment:1. Check (payable through U.S. banks only)2. Money order3. Credit cards (MasterCard, VISA, and American Express)4. Cash (on-site registration)

A receipt and confirmation letter will be sent to you within 10 working days of receipt of your fee.

The full conference registration fee includes tuition, continental breakfast, box lunch, and breaks.

Special AssistanceContact the Department of CME/Conference Management at 713-792-2223 or 866-849-5866 if you have any special dietary or ADA accommodation needs.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable exptertise on rare occasions necessitated by illness, scheduling conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.